HEALIUS LIMITED — Director's Dealing 2018

Jan 2, 2018

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	PRIMARY HEALTH CARE LIMITED
ABN	24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Robert Ferguson
Date of last notice	1 July2009

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest
(including registered holder)	As shown
Note: Provide details of the circumstances giving
rise to therelevantinterest.
Date of change	21 December 2017
No. of securities held prior tochange	Invia Custodian PtyLimited - Torryburn SF -Fixed In A/C	190,800
Class	Fully paid ordinary shares
Number acquired	100,000
Number disposed	Not applicable
Value/Consideration
Note: If consideration is non-cash, provide details	$3.6200 per share
and estimated valuation
No. of securities held afterchange	Invia Custodian PtyLimited - Torryburn SF -Fixed In A/C	290,800

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under On-market trade dividend reinvestment plan, participation in buyback

Part 2 – Change of director’s interests in contracts Not applicable

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written clearance was required?

If so, was prior written clearance provided to allow the trade to proceed during this period?

If prior written clearance was provided, on what date was this provided?

Not applicable Not applicable Not applicable

Charles Tilley Company Secretary Date: 3 January 2018

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011